Abstract
The transcriptional coactivator with PDZ-binding motif (TAZ), which is encoded by the WWTR1 gene, is a key transcriptional effector of the Hippo signaling pathway. TAZ function has been implicated in a variety of developmental processes and diseases, most notably in driving oncogenesis. Given that nuclear-cytoplasmic localization dynamics dictate TAZ activity, techniques for visualizing TAZ localization are critical for its study. Here we describe an immunofluorescence microscopy protocol that allows for the visualization of TAZ subcellular localization in mammalian cells, offering an approach that can aid in the analysis of TAZ regulation and function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fu V, Plouffe SW, Guan KL (2018) The Hippo pathway in organ development, homeostasis, and regeneration. Curr Opin Cell Biol 49:99–107. https://doi.org/10.1016/j.ceb.2017.12.012
Varelas X (2014) The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 141(8):1614–1626. https://doi.org/10.1242/dev.102376
Mahoney WM Jr, Hong JH, Yaffe MB, Farrance IK (2005) The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J 388(Pt 1):217–225. https://doi.org/10.1042/BJ20041434
Zhang H, Liu CY, Zha ZY, Zhao B, Yao J, Zhao S, Xiong Y, Lei QY, Guan KL (2009) TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem 284(20):13355–13362. https://doi.org/10.1074/jbc.M900843200
Hiemer SE, Szymaniak AD, Varelas X (2014) The transcriptional regulators TAZ and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells. J Biol Chem 289(19):13461–13474. https://doi.org/10.1074/jbc.M113.529115
Levasseur A, St-Jean G, Paquet M, Boerboom D, Boyer A (2017) Targeted disruption of YAP and TAZ impairs the maintenance of the adrenal cortex. Endocrinology 158(11):3738–3753. https://doi.org/10.1210/en.2017-00098
Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A, Yabuta N, Hirahara S, Stephenson RO, Ogonuki N, Makita R, Kurihara H, Morin-Kensicki EM, Nojima H, Rossant J, Nakao K, Niwa H, Sasaki H (2009) The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell 16(3):398–410. https://doi.org/10.1016/j.devcel.2009.02.003
Poitelon Y, Lopez-Anido C, Catignas K, Berti C, Palmisano M, Williamson C, Ameroso D, Abiko K, Hwang Y, Gregorieff A, Wrana JL, Asmani M, Zhao R, Sim FJ, Wrabetz L, Svaren J, Feltri ML (2016) YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells. Nat Neurosci 19(7):879–887. https://doi.org/10.1038/nn.4316
Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J, Porrello ER, Mahmoud AI, Tan W, Shelton JM, Richardson JA, Sadek HA, Bassel-Duby R, Olson EN (2013) Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci U S A 110(34):13839–13844. https://doi.org/10.1073/pnas.1313192110
Reginensi A, Hoshi M, Boualia SK, Bouchard M, Jain S, McNeill H (2015) Yap and Taz are required for Ret-dependent urinary tract morphogenesis. Development 142(15):2696–2703. https://doi.org/10.1242/dev.122044
Meng Z, Moroishi T, Guan KL (2016) Mechanisms of Hippo pathway regulation. Genes Dev 30(1):1–17. https://doi.org/10.1101/gad.274027.115
Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC, Yaffe MB (2000) TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 19(24):6778–6791. https://doi.org/10.1093/emboj/19.24.6778
Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, Xiong Y, Guan KL (2008) TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28(7):2426–2436. https://doi.org/10.1128/MCB.01874-07
Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, Li T, Chan SW, Lim CJ, Hong W, Zhao S, Xiong Y, Lei QY, Guan KL (2010) The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J Biol Chem 285(48):37159–37169. https://doi.org/10.1074/jbc.M110.152942
Moroishi T, Hansen CG, Guan KL (2015) The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer 15(2):73–79. https://doi.org/10.1038/nrc3876
Zanconato F, Cordenonsi M, Piccolo S (2016) YAP/TAZ at the roots of cancer. Cancer Cell 29(6):783–803. https://doi.org/10.1016/j.ccell.2016.05.005
Beyer TA, Weiss A, Khomchuk Y, Huang K, Ogunjimi AA, Varelas X, Wrana JL (2013) Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep 5(6):1611–1624. https://doi.org/10.1016/j.celrep.2013.11.021
Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, Larsen BG, Rossant J, Wrana JL (2010) The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell 19(6):831–844. https://doi.org/10.1016/j.devcel.2010.11.012
Reginensi A, Scott RP, Gregorieff A, Bagherie-Lachidan M, Chung C, Lim DS, Pawson T, Wrana J, McNeill H (2013) Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLoS Genet 9(3):e1003380. https://doi.org/10.1371/journal.pgen.1003380
Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA, Moffat J, Golland P, Sabatini DM (2006) CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7(10):R100. https://doi.org/10.1186/gb-2006-7-10-r100
Acknowledgments
We would like to thank Dr. Jeffrey Wrana (Lunenfeld-Tanenbaum Research Institute, Toronto, Canada) for providing the Taz-loxP/loxP mice. X.V. is supported by NIH R01HL124392, the March of Dimes Foundation Grant no. 1-FY17-375, and an American Cancer Society Ellison New England Research Scholar Grant (RSG-17-138-01-CSM). N. M. K. is supported by NIH T32HL007035-40. J.H.B. is supported by NIH F31HL13250601.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kingston, N.M., Tilston-Lunel, A.M., Hicks-Berthet, J., Varelas, X. (2019). Immunofluorescence Microscopy to Study Endogenous TAZ in Mammalian Cells. In: Hergovich, A. (eds) The Hippo Pathway. Methods in Molecular Biology, vol 1893. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8910-2_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8910-2_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8909-6
Online ISBN: 978-1-4939-8910-2
eBook Packages: Springer Protocols